Question 1

Does Natixis own KYMR stock?

Accepted Answer

No. Natixis exited its KYMR (Kymera Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 2,595 shares worth $113,246.

Question 2

How many shares of KYMR does Natixis own?

Accepted Answer

None since Q3 2025, when Natixis exited the position. Its Q2 2025 13F listed 2,595 shares worth $113,246.

Question 3

What is Natixis' KYMR position worth?

Accepted Answer

Natixis' KYMR position was worth $113,246 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Natixis buying or selling KYMR?

Accepted Answer

In Q3 2025, Natixis exited its entire KYMR position.

Question 5

When did Natixis first buy KYMR?

Accepted Answer

Natixis first reported KYMR in its Q2 2021 13F and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$56.60	0
2025-Q2	Decreased	2,595	-79.5%	$113,246	0.0%	$43.64	0
2025-Q1	New	12,674	—	$355,759	0.0%	$27.37	33